Pharsight

WYETH PATENTS FACING OPPOSITIONS

Top patents of WYETH facing oppositions at the European Patent Office (EPO)

Patent Number Grant Date Patent Title Expected Expiration Date Facing Oppositions Activity Alert
EP1869065B1 06 May, 2020 A Method Of Weak Partitioning Chromatography NA 4
EP2188371B1 20 Dec, 2017 Use Of Perfusion To Enhance Production Of Fed-Batch Cell Culture In Bioreactors NA 4
EP3000467B1 01 Mar, 2023 Treatment Regimen Utilizing Neratinib For Breast Cancer Mar, 2030 3
EP2676679B1 02 Jan, 2019 Formulations Which Stabilize And Inhibit Precipitation Of Immunogenic Compositions NA 3
EP3255141B1 01 Dec, 2021 Production Of Antibodies With Improved Glycosylation Pattern NA 2
EP2059258B1 13 Nov, 2019 Arginine Wash In Protein Purification Using Affinity Chromatography Sep, 2027 2
EP3225233B1 14 Aug, 2019 Sodium Chloride Solution For Drug Reconstitution Or Dilution Oct, 2026 2
EP3246044B2 10 Apr, 2024 Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens Aug, 2031 1
EP1942868B2 04 Oct, 2023 Sodium Chloride Solution For Drug Reconstitution Or Dilution NA 1
EP2498756B2 15 Feb, 2023 Tablet Formulations Of Neratinib Maleate NA 1
EP3002009B1 07 Jul, 2021 Treatment Of Imatinib Resistant Leukemia Using 4-Aminoquinoline-3-Carbonitriles May, 2028 1
EP3549601B1 24 Feb, 2021 Non-Lipidated Variants Of Neisseria Meningitidis Orf2086 Antigens Sep, 2031 1
EP2924113B1 10 Apr, 2019 Use Of Copper And Glutamate In Cell Culture For Production Of Polypeptides NA 1
EP2368914B1 02 Jan, 2019 Anti-5T4 Antibodies And Uses Thereof Mar, 2027 1
EP2495307B9 02 May, 2018 Production Of Glycoproteins NA 1
EP2139986B1 06 Sep, 2017 Use Of Low Temperature And/Or Low Ph In Cell Culture NA 1
EP2608805B1 05 Jul, 2017 Stable Formulations Of Neisseria Meningitidis Rlp2086 Antigens NA 1